Alle Storys
Folgen
Keine Story von Medicsight Inc. mehr verpassen.

Medicsight Inc.

Medicsight PLC Announces Agreements for Global Distribution of Three Medical Imaging Software Products

London, November 23 (ots/PRNewswire)

- Agfa, Vital Images, and Viatronix to Use Medicsight Software
Medicsight Inc.'s (OTC Bulletin Board: MSHT) majority owned
subsidiary, Medicsight PLC ("Medicsight"), announced today that it
has signed letters of intent with Agfa-Gevaert N.V. and Viatronix and
a commercial agreement with Vital Images for global distribution of
Medicsight's medical imaging software products. These agreements are
the first of their kind for Medicsight and represent a major step
forward in the company's plans to commercialize its advanced imaging
technology on a worldwide basis. The intent is to incorporate
Medicsight's software into the three companies' existing product
offerings.
"The letters of intent and commercial agreement are major
milestones for Medicsight in reaching our goal of being the leading
global supplier of medical imaging analysis software," said Paul
Samuel, Medicsight CEO. "We look forward to working with Agfa, Vital
Images, and Viatronix to integrate our software into their systems.
We believe these partnerships demonstrate the significant value of
the Medicsight software and clearly show how our software can
differentiate existing offerings of imaging companies."
Medicsight's software will be demonstrated at the exhibitor booths
of Agfa, Vital Images, and Viatronix during the annual meeting of the
Radiological Society of North America (RSNA). The RSNA trade show
opens Nov. 28 and runs through Dec. 3 at McCormick Place in Chicago.
"Integrating the Medicsight portfolio in our market leading
solution fits into our strategy of offering best-of-breed solutions
to the radiologist and clinician through intelligent strategic
alliances," said Etienne Vanderstokker, head of Medical Imaging
Technologies, Business Group Healthcare, Agfa. "It's a successful and
award-winning strategy that has been fully appreciated by the market
and has strengthened Agfa's capability to penetrate new markets and
to remain on top of technological innovations."
Vital Images will be integrating Medicsight's Colon CAR(TM)
software into its CT colon product InnerviewGI(TM). "We are excited
about further enhancing our colon offering with Medicsight's CAR
image-analysis technology," said Jay D. Miller, president and chief
executive officer, Vital Images. "This partnership together further
demonstrates our commitment to the oncology marketplace and more
specifically to the application of virtual colonoscopy."
The letter of intent signed by Viatronix and Medicsight includes
Medicsight's Lung CAR(TM) and Colon CAR(TM) software. "We believe
computer assisted read (CAR) technology provides an important tool
for the radiologist and greatly enhances their diagnostic
capability," said Zaffar Hayat, CEO and president of Viatronix
Incorporated. "The integration of Medicsight's Lung and Colon CAR
software with our products will greatly complement our advanced
medical imaging solutions."
The Medicsight products covered by these agreements are:
- Medicsight Colon CAR(TM), an image-analysis software tool designed to
      be used with CT (computed tomography) colonography (virtual
      colonoscopy) to assist radiologists in searching for and measuring
      potential colorectal polyps.  Colon CAR 1.2(TM), which uses
      Medicsight's Computer Assisted Reader (CAR) technology to deploy a
      series of filters against image data derived from CT colonographies,
      received clearance from the U.S. Food and Drug Administration (FDA) in
      October 2004. Colon CAR(TM) is the first joint-read software product
      available for CT scans of the colon.
    - Medicsight Lung CAR(TM) (Computer Assisted Reader), an image-analysis
      software tool that assists radiologists in evaluating lesions or
      nodules found during CT scans of the lung. Medicsight Lung CAR 1.1(TM)
      received FDA clearance in August 2004. Lung CAR(TM) is the first joint-
      read software product available for CT scans of the lung.
    - Medicsight Heart Screen(TM), an update to the company's MedicHeart
      1.0(TM) heart imaging software that features a newly designed user
      interface. Medicsight Heart Screen is an image-analysis software tool
      for CT scans that assists radiologists and cardiologists in identifying
      and quantifying coronary artery calcification.
Samuel said Medicsight would continue to pursue other distribution
agreements as well. "We're looking for quality partners who share our
vision of taking software beyond detection to diagnosis and patient
management and who can help broaden our reach in the marketplace," he
said. "We will also continue to focus on deepening our established
relationships."
About Agfa
The Agfa-Gevaert Group is one of the world's leading imaging
companies. Agfa develops, manufactures and markets analogue and
digital systems, intended mainly for the graphics industry and the
healthcare markets.
Agfa's headquarters are in Mortsel, Belgium. The company is active
in 40 countries and has agents in another 100 countries throughout
the world. Together they achieved a turnover of 4,215 million euros
in 2003.
Product and company information can be found on Agfa's home page
on the World Wide Web at: http://www.agfa.com.
Agfa, the Agfa rhombus, IMPAX and See More. Do More. are
trademarks of Agfa-Gevaert N.V., Belgium or its affiliates. All
rights reserved.
About Vital Images
Vital Images, headquartered in Minneapolis, Minnesota, is a
leading provider of advanced medical imaging software for use in
disease screening applications, clinical diagnosis and therapy
planning. The company's technology utilizes high-speed volume
visualization and analysis, as well as network communications based
on DICOM and Internet protocols. Vital Images cost effectively brings
advanced visualization and analysis into the day-to-day practice of
medicine. Press releases, examples of advanced medical imaging and
other corporate information are available on Vital Images' Web site
at http://www.vitalimages.com.
About Viatronix, Inc.
Viatronix is a leading innovator and developer of diagnostic 3D
imaging software, which enables physicians to interactively view
patients' vital organs and anatomical structures. The Viatronix
PACS-integratable V3D-Explorer has patent protected technology that
enables 3D visualization of organs from patient data acquired by
standard imaging equipment via minimally invasive or non-invasive
methods. The Viatronix V3D-Colon allows physicians to interactively
view the colon reconstructed from a CT scan, providing visualization
of the inner surface of the colon, including polyps. The Viatronix
V3D-Calcium Scoring aids physicians in determining the amount of
calcium plaque accumulation in the coronary arteries. V3D-Vascular is
the latest addition to the V3D System. In seconds, this breakthrough
software permits rapid segmentation and visualization of complex
arterial structures using 3D volume rendering, maximum intensity
projection and simulated x-ray views. Viatronix, through application
of its V3D technology, is developing additional innovative products
that will be useful for earlier detection of diseases, treatment
planning, and follow-up evaluation.
Viatronix, Inc. is located in Stony Brook, NY. For further
information, call toll free +1-(866)-887-4636 or log on to
http://www.viatronix.com.
About Medicsight
Medicsight is a software development business focused on the
medical imaging market. The company is using its core technology to
develop automatic detection and analytical tools for clinicians to
improve their ability to diagnose and treat disease, initially
focusing on three key clinical areas -- lung cancer, colon cancer,
and coronary heart disease. Medicsight's software will enable earlier
and more accurate detection and treatment of suspicious lesions,
which can save lives and reduce healthcare costs. Headquartered in
London, Medicsight employs more than 60 people and has offices in the
U.K., United States, and China. Product and company information can
be found on http://www.medicsight.com. Stock symbol: OTCBB:MSHT.
Web site: http://www.medicsight.com
              http://www.agfa.com
              http://www.vitalimages.com
              http://www.viatronix.com

Contact:

Cara Ramsay, Fleishman-Hillard, +1-314-982-7772, for Medicsight;
David Sumner, +44-20-7598-4080, Medicsight International Marketing
Director, or David Mason, +1-615-665-9007, Medicsight Investor
Relations